These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37452073)

  • 1. Drug resistance profiling of asymptomatic and low-density Plasmodium falciparum malaria infections on Ngodhe island, Kenya, using custom dual-indexing next-generation sequencing.
    Osborne A; Phelan JE; Kaneko A; Kagaya W; Chan C; Ngara M; Kongere J; Kita K; Gitaka J; Campino S; Clark TG
    Sci Rep; 2023 Jul; 13(1):11416. PubMed ID: 37452073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana.
    Dosoo DK; Bailey JA; Asante KP; Oppong FB; Niaré K; Opoku-Mensah J; Owusu-Agyei S; Greenwood B; Chandramohan D
    PLoS One; 2022; 17(8):e0271489. PubMed ID: 35939419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
    Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
    Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
    Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral and Placental Prevalence of Sulfadoxine-Pyrimethamine Resistance Markers in Plasmodium falciparum among Pregnant Women in Southern Province, Rwanda.
    Alruwaili M; Uwimana A; Sethi R; Murindahabi M; Piercefield E; Umulisa N; Abram A; Eckert E; Munguti K; Mbituyumuremyi A; Gutman JR; Sullivan DJ
    Am J Trop Med Hyg; 2023 Nov; 109(5):1057-1062. PubMed ID: 37783456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
    Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
    Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of highly sulfadoxine-resistant dihydropteroate synthase alleles in Plasmodium falciparum isolates in Benin.
    Svigel SS; Adeothy A; Kpemasse A; Houngbo E; Sianou A; Saliou R; Patton ME; Dagnon F; Halsey ES; Tchevoede A; Udhayakumar V; Lucchi NW
    Malar J; 2021 Feb; 20(1):72. PubMed ID: 33546703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
    Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
    PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
    Gikunju SW; Agola EL; Ondondo RO; Kinyua J; Kimani F; LaBeaud AD; Malhotra I; King C; Thiong'o K; Mutuku F
    Malar J; 2020 May; 19(1):190. PubMed ID: 32448228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo.
    Ruh E; Bateko JP; Imir T; Taylan-Ozkan A
    Malar J; 2018 Jan; 17(1):17. PubMed ID: 29316929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
    Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
    PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
    Chauvin P; Menard S; Iriart X; Nsango SE; Tchioffo MT; Abate L; Awono-Ambéné PH; Morlais I; Berry A
    J Antimicrob Chemother; 2015 Sep; 70(9):2566-71. PubMed ID: 26080363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria.
    Fagbemi KA; Adebusuyi SA; Nderu D; Adedokun SA; Pallerla SR; Amoo AOJ; Thomas BN; Velavan TP; Ojurongbe O
    Infect Genet Evol; 2020 Nov; 85():104503. PubMed ID: 32805431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
    Spalding MD; Eyase FL; Akala HM; Bedno SA; Prigge ST; Coldren RL; Moss WJ; Waters NC
    Malar J; 2010 Nov; 9():338. PubMed ID: 21106088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin.
    L'Episcopia M; Doderer-Lang C; Perrotti E; Priuli GB; Cavallari S; Guidetti C; Bernieri F; Menard D; Severini C
    Acta Trop; 2023 Sep; 245():106975. PubMed ID: 37348801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
    Khattak AA; Venkatesan M; Jacob CG; Artimovich EM; Nadeem MF; Nighat F; Hombhanje F; Mita T; Malik SA; Plowe CV
    Malar J; 2013 Aug; 12():300. PubMed ID: 23988011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019.
    Rosillo SR; Dimbu PR; Cândido ALM; Oh JM; Ferreira CM; Nieto Andrade B; Labuda S; Horth R; Kelley J; Morais JFM; Fortes F; Martins JF; Talundzic E; Pluciński MM
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0160122. PubMed ID: 36916920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.